The Company is committed to expanding and accelerating vaccine supply to the African region through 2022 and beyond to help governments reach their vaccination targets One year ago, the first doses of the AstraZeneca...
Positive results from a preliminary analysis of an ongoing safety and immunogenicity trial (D7220C00001) showed that AstraZeneca COVID-19 vaccine (ChAdOx1-S [Recombinant]), when given as a third dose booster, increased the immune response to Beta,...
Ghana today received 98,400 doses of COVID-19 Vaccine AstraZeneca that were donated by Norway through the COVAX facility. COVAX is a global initiative co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi (the...
